mRNA Vaccine Incorporated with Immunostimulatory Adjuvant Functionality (IMAGE)

Innovation Center of NanoMedicine

mRNA Vaccine Incorporated with Immunostimulatory Adjuvant Functionality

Caption

In order for mRNA vaccine to function, it is required not only to efficiently introduce mRNA into antigen-presenting cells but also to activate them for effective antibody production. Substances that enhance the action of vaccines in this way are called "adjuvants." The introduction of adjuvants and mRNA into the same antigen-presenting cells enables them to effectively induce immunity to the antigen.

Credit

2020 Innovation Center of NanoMedicine

Usage Restrictions

All rights reserved

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.